X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
radiation-sensitizing agents - pharmacology (3888) 3888
humans (2975) 2975
science & technology (2835) 2835
animals (2748) 2748
life sciences & biomedicine (2725) 2725
oncology (1595) 1595
mice (1515) 1515
cell survival - drug effects (1072) 1072
cell line, tumor (1043) 1043
female (1009) 1009
cell survival - radiation effects (878) 878
male (783) 783
dose-response relationship, radiation (633) 633
radiotherapy (617) 617
apoptosis - drug effects (611) 611
radiation-sensitizing agents (604) 604
radiation-sensitizing agents - therapeutic use (572) 572
radiology, nuclear medicine & medical imaging (569) 569
dose-response relationship, drug (558) 558
antineoplastic agents - pharmacology (518) 518
cancer (516) 516
apoptosis (506) 506
radiation (495) 495
radiation tolerance - drug effects (489) 489
tumor cells, cultured (443) 443
cell line (439) 439
space life sciences (438) 438
pharmacology & pharmacy (429) 429
combined modality therapy (427) 427
apoptosis - radiation effects (419) 419
cricetinae (419) 419
dna damage (419) 419
time factors (409) 409
biochemistry & molecular biology (399) 399
radiation effects (394) 394
radiosensitization (389) 389
rats (370) 370
mice, nude (363) 363
oxygen (355) 355
nitroimidazoles - pharmacology (342) 342
tumors (329) 329
radiosensitivity (325) 325
hypoxia (323) 323
radiation-sensitizing agents - administration & dosage (321) 321
xenograft model antitumor assays (321) 321
cell proliferation - drug effects (312) 312
neoplasms - radiotherapy (311) 311
radiation tolerance (309) 309
cell cycle (308) 308
irradiation (303) 303
biophysics (301) 301
biology (295) 295
cell cycle - drug effects (295) 295
gamma rays (287) 287
cells, cultured (284) 284
radiation therapy (279) 279
radiation-sensitizing agents - chemistry (275) 275
dna repair (272) 272
dna repair - drug effects (268) 268
radiosensitizers (260) 260
drugs (256) 256
photochemotherapy (255) 255
in vitro techniques (251) 251
radiation, thermal, and other environ. pollutant effects on living orgs. and biol. mat (241) 241
care and treatment (236) 236
research (234) 234
mice, inbred balb c (232) 232
light (231) 231
tumor cells, cultured - drug effects (221) 221
research article (219) 219
neoplasms - drug therapy (216) 216
proteins (216) 216
chemotherapy (214) 214
dna (214) 214
misonidazole - pharmacology (212) 212
life sciences & biomedicine - other topics (210) 210
cancer therapies (205) 205
flow cytometry (203) 203
neoplasm transplantation (203) 203
organic compounds (200) 200
cricetulus (199) 199
radiation dosage (197) 197
ionizing radiation (196) 196
x-rays (195) 195
cell biology (189) 189
radiation-sensitizing agents - pharmacokinetics (189) 189
oxygen - pharmacology (188) 188
cell cycle - radiation effects (186) 186
enzyme inhibitors - pharmacology (184) 184
chemistry (181) 181
mice, inbred c3h (181) 181
radiosensitivity effects (180) 180
kinetics (179) 179
radiation-sensitizing agents - metabolism (177) 177
ultraviolet rays (177) 177
cell division - drug effects (176) 176
organic nitrogen compounds (176) 176
lung neoplasms - radiotherapy (173) 173
cell proliferation - radiation effects (172) 172
tumor cells, cultured - radiation effects (172) 172
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (4862) 4862
Russian (125) 125
Japanese (92) 92
Chinese (88) 88
German (56) 56
French (37) 37
Italian (19) 19
Spanish (8) 8
Polish (5) 5
Portuguese (3) 3
Dutch (2) 2
Hungarian (2) 2
Bulgarian (1) 1
Croatian (1) 1
Czech (1) 1
Finnish (1) 1
Lithuanian (1) 1
Romanian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Clinical cancer research, ISSN 1557-3265, 10/2008, Volume 14, Issue 20, pp. 6456 - 6468
Purpose: It was the aim of our study to establish an extensive panel of non-small cell lung cancer (NSCLC) xenograft models useful for the testing of novel... 
xenograft | NSCLC | erlotinib | mutational analysis | anti-EGFR therapy | cetuximab | biomarker | Life Sciences & Biomedicine | Oncology | Science & Technology | Carcinoma, Large Cell - drug therapy | Lung Neoplasms - drug therapy | Receptor, Epidermal Growth Factor - genetics | Adenocarcinoma - pathology | Oligonucleotide Array Sequence Analysis | Carcinoma, Large Cell - pathology | Carcinoma, Squamous Cell - pathology | Humans | Lung Neoplasms - metabolism | Middle Aged | Drug Resistance, Neoplasm | Immunoblotting | Male | Gene Expression Profiling | Adenocarcinoma - metabolism | Biomarkers, Tumor - metabolism | Cetuximab | Disease Models, Animal | Genes, ras - genetics | Antibodies, Monoclonal - pharmacology | Carcinoma, Non-Small-Cell Lung - metabolism | Etoposide - pharmacology | Mutation - genetics | Adenocarcinoma - drug therapy | Small Cell Lung Carcinoma - pathology | Carcinoma, Squamous Cell - drug therapy | Mice, Nude | Mice, Inbred NOD | Biomarkers, Tumor - genetics | Mice | Carboplatin - pharmacology | Quinazolines - pharmacology | Deoxycytidine - analogs & derivatives | Erlotinib Hydrochloride | Paclitaxel - pharmacology | Prognosis | Carcinoma, Squamous Cell - metabolism | Deoxycytidine - pharmacology | Lung Neoplasms - pathology | Small Cell Lung Carcinoma - drug therapy | Tumor Suppressor Protein p53 - genetics | Small Cell Lung Carcinoma - metabolism | Antibodies, Monoclonal, Humanized | Receptor, Epidermal Growth Factor - metabolism | Vinblastine - analogs & derivatives | Polymerase Chain Reaction | Adult | Female | Antineoplastic Agents - pharmacology | Carcinoma, Non-Small-Cell Lung - pathology | Carcinoma, Large Cell - metabolism | Radiation-Sensitizing Agents - pharmacology | Tumor Suppressor Protein p53 - metabolism | Mice, SCID | Xenograft Model Antitumor Assays | Animals | Receptor, Epidermal Growth Factor - antagonists & inhibitors | Aged | Protein Kinase Inhibitors - pharmacology | Vinblastine - pharmacology | Carcinoma, Non-Small-Cell Lung - drug therapy | Antineoplastic Agents, Phytogenic - pharmacology | Index Medicus
Journal Article
Neuroscience, ISSN 0306-4522, 2017, Volume 346, pp. 298 - 308
Highlights • GDC-0941 monotherapy induced cytotoxicity and showed pro-apoptotic effects in. • glioblastoma multiforme (GBM) cell lines. • GDC-0941 enhanced the... 
Neurology | TMZ | radiotherapy | glioma | GDC-0941 | chemotherapy | PI3K inhibitor | Neurosciences | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Apoptosis - drug effects | Dacarbazine - therapeutic use | Phosphatidylinositol 3-Kinase - antagonists & inhibitors | Humans | Brain Neoplasms - pathology | Antineoplastic Agents, Alkylating - pharmacology | Antineoplastic Agents - therapeutic use | Glioblastoma - radiotherapy | Radiation-Sensitizing Agents - therapeutic use | Dacarbazine - pharmacology | Dacarbazine - analogs & derivatives | Antineoplastic Agents - pharmacology | Brain Neoplasms - radiotherapy | Phosphatidylinositol 3-Kinase - metabolism | Cell Survival - drug effects | Neoplasm Invasiveness | Radiation-Sensitizing Agents - pharmacology | Antineoplastic Combined Chemotherapy Protocols | Brain Neoplasms - drug therapy | Sulfonamides - pharmacology | Antineoplastic Agents, Alkylating - therapeutic use | Glioblastoma - therapy | Indazoles - pharmacology | Cell Movement - drug effects | Signal Transduction - drug effects | Sulfonamides - therapeutic use | Glioblastoma - pathology | Brain Neoplasms - therapy | Cell Line, Tumor | Cell Cycle - drug effects | Glioblastoma - drug therapy | Indazoles - therapeutic use | Antimitotic agents | Tumor proteins | Antineoplastic agents | Chemotherapy | Gliomas | Analysis | Cancer | Index Medicus
Journal Article
Redox biology, ISSN 2213-2317, 12/2015, Volume 6, pp. 1 - 8
Journal Article
Current medicinal chemistry, ISSN 0929-8673, 01/2019, Volume 26, Issue 35, pp. 6493 - 6513
Journal Article
Journal of pharmaceutical sciences, ISSN 0022-3549, 03/2015, Volume 104, Issue 3, pp. 962 - 970
Carboranyl-containing chlorins have emerged as promising dual sensitizers for use in both photodynamic therapy (PDT) and boron neutron capture therapy (BNCT),... 
PDT | BNCT | blood–brain barrier | CED | absorption | cell culture | boron-containing chlorin | CNS | osmotic pumps | TPFC | boron‐containing chlorin | Cell culture | Absorption | Blood-brain barrier | Osmotic pumps | Boron-containing chlorin | Physical Sciences | Chemistry | Life Sciences & Biomedicine | Pharmacology & Pharmacy | Chemistry, Medicinal | Chemistry, Multidisciplinary | Science & Technology | Porphyrins - administration & dosage | Phenylalanine - analogs & derivatives | Phenylalanine - pharmacology | Photochemotherapy - methods | Rats, Inbred F344 | Brain Neoplasms - pathology | Male | Porphyrins - pharmacokinetics | Radiation-Sensitizing Agents - pharmacokinetics | Boron Compounds - administration & dosage | Photosensitizing Agents - administration & dosage | Tissue Distribution | Photosensitizing Agents - pharmacology | Radiation-Sensitizing Agents - administration & dosage | Boron Compounds - chemical synthesis | Glioma - pathology | Glioma - therapy | Radiation-Sensitizing Agents - chemical synthesis | Photosensitizing Agents - chemical synthesis | Boron Compounds - pharmacology | Cell Survival - drug effects | Radiation-Sensitizing Agents - pharmacology | Porphyrins - chemical synthesis | Boron Compounds - pharmacokinetics | Porphyrins - pharmacology | Cell Survival - radiation effects | Boron Neutron Capture Therapy - methods | Animals | Brain Neoplasms - therapy | Cell Line, Tumor | Photosensitizing Agents - pharmacokinetics | Microscopy, Fluorescence | Index Medicus
Journal Article
Journal Article
Journal Article